More info about CENTREX (CNEX.OB)CNEX (OTCBB)
About Centrex, Inc.: Centrex, Inc., a development stage company, owns the exclusive worldwide license to develop, manufacture and market a system for the rapid, inexpensive and reliable detection of specific microbial contaminants in air, food and water. Centrex’s Single Molecule Detection (SMD) technology, developed at Los Alamos National Laboratory, recognizes specific nucleic acid sequences (DNA or RNA). SMD is an emerging field within bio-nanotechnology concerned with identification, classification, spatial orientation and manipulation of minute quantities of individual molecules. The Centrex SMD technology can quickly detect bacteria or viruses by identifying the DNA (or RNA) of the bacteria or virus. Contrasted with other types of DNA identification, SMD requires far smaller test samples and hence is very sensitive and fast. The SMD method is especially attractive for bioagent sensors because of its discrimination, accuracy and speed. It offers the potential for early warning combined with high sensitivity and accurate identification of biological weapons agents
http://www.centrexcorporation.com/Centrex/Press/03/030825a.htm
Other Interesting Links:
Centrex & Micronics pact: http://www.micronics.net/news/news_release_detail.php?nr_id=40
More Single Molecule Detection news: http://www.biospace.com/news_story.cfm?StoryID=14102220&full=1
Centrex and Emergency Filtration (OTCBB EMFP)link http://www.centrexcorporation.com/Centrex/Press/03/030107a.htm